Radiology, News, Education, Service

Since the beginning of the pandemic, there has been a growing realisation amongst clinicians to start embracing smarter technology to achieve better workflow efficiency and clinical confidence across the patient pathway.

HOLOGIC'S 3DIMENSIONS™ MAMMOGRAPHY SYSTEM

Hologic's 3Dimensions™ mammography system has become smarter, bringing breast cancer screening to a new level of improving cancer detection accuracy, optimising workflow, and supporting personalised patient care. The integrated AI powered software solutions employ machine learning and deep learning algorithms developed and trained on a high number of varied Hologic tomosynthesis images to aid cancer detection, assess breast density and accelerate diagnosis.

ENHANCED WORKFLOW EFFICIENCY

Using artificial intelligence (AI) algorithms to preserve clinical information, Hologic's 3DQuorum™ imaging technology, powered by Genius AI™*, uniquely reconstructs high-resolution tomosynthesis slices to create 6mm SmartSlices at the point of care.¹ When a Radiologist reads SmartSlices instead of 1mm tomosynthesis slices, the number of 3D images to review is reduced by 66%,²^,³ leading to average interpretation time saving of one hour per day, based on eight hours of image interpretation time.⁴

3DQuorumT imaging technology, powered by Genius AIT*

In addition, 3DQuorum technology reduces the typical Hologic high resolution Clarity HD^® and Intelligent 2D™ file size by over 50%, bringing the storage space and network impact back down to that of standard resolution 3D imaging.⁵

MAXIMUM CLINICAL CONFIDENCE

The addition of Genius AI™ Detection technology to the 3D mammography system allows technologists to flag high risk cases for immediate reading, meaning that radiologists can detect breast cancer with higher confidence.

Using deep learning technology, advanced artificial intelligence algorithms highlight points of interest that could potentially be cancerous. The algorithm is trained using a high-volume image database and is intended for current reading to aid interpretation. In addition to identifying potential cancers, Genius AI Detection software provides case level metrics allowing you to categories cases for priority reading enhancing your workflow.

PERSONALISED SCREENING

Where AI might really come into its own is risk stratification for women with dense breast tissue, known to be at particularly high risk of developing breast cancer. Compatible with images acquired from Hologic's mammography systems, Quantra™ breast density assessment software, applies machine-learning to analyse each patient's individual breast pattern and texture, providing objective assessments of breast density (using ACR BIRADS^® Atlas Fifth Edition criteria).

Therefore, a fully automated methodology can offer a completely unbiased and reproducible option to assess and report breast density category. Hologic is excited to be at the forefront of offering AI solutions which ultimately unlock the advantage of time for our patients, ensuring the best possible experiences and outcomes.

Our patients are at the heart of everything we do, both in the clinical setting and beyond. There is still much to be done, however the future of mammography with the inclusion of AI solutions seems a promising one.

Learn more about Hologic's smarter breast screening using integrated AI solutions

Explore our scientific webinar series to learn more:

Breast & Skeletal Health | www.3dimensionsmammography.eu | euinfo@hologic.com

Hologic BV, Da Vincilaan 5, 1930 Zaventem, Belgium

*Disclaimer: Genius AI Detection is not CE marked, not for sale in Europe yet.

References 1. Hologic data on file. DHM-08611. 2. MAN-066153. Dimensions Breast Tomo. 3. MAN-06029. 3DQuorum. 4. Hologic data on file. CSR-00116. 5. Hologic data on file. TFL-0059.

EMB-01871-EUR-EN Rev 001. ©2022 Hologic, Inc. All rights reserved. Hologic, 3Dimensions, 3DQuorum, Clarity HD, Genius AI, Intelligent 2D, Quantra, and associated logos are trademarks or registered trademarks of Hologic, Inc. and/or its subsidiaries in the United States and/or other countries. All other trademarks, registered trademarks and product names are the property of their respective owners. This information is intended for medical professionals and is not intended as a product solicitation or promotion where such activities are prohibited. Because Hologic materials are distributed through websites, eBroadcasts and tradeshows, it is not always possible to control where such materials appear. For information on specific products available for sale in a particular country, please contact your Hologic representative or write to euinfo@hologic.com